| |
| |
|
| Insider
Information: |
Kingsley Alfred D |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
5,968,356 |
|
|
Indirect Shares
|
1,512,809 |
|
|
| Direct
Value |
$5,137,134 |
|
|
|
Indirect Value
|
$1,323,637 |
|
|
| Total
Shares |
7,481,165 |
|
|
| Total
Value |
$6,460,771 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
3
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
3
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-3.0
|
3.0
|
| Percentage
Gain/Loss : |
 -38.5%
|
 148.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Lineage Cell Therapeutics Ord Shs |
LCTX |
Director |
2021-06-22 |
5,470,245 |
2021-06-22 |
1,418,697 |
Premium* |
|
|
Asterias Biotherapeutics Inc |
AST |
Director |
2016-06-09 |
9,000 |
2015-06-25 |
0 |
Premium* |
|
|
Oncocyte Corp |
OCX |
Director |
2023-06-23 |
489,111 |
2023-06-23 |
94,112 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OCX |
Oncocyte Corp |
Director |
– • – |
2015-12-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
94,112 |
|
- |
|
| OCX |
Oncocyte Corp |
Director |
– • – |
2015-12-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
296,902 |
|
- |
|
| OCX |
Oncocyte Corp |
Director |
– • – |
2020-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,909 |
302,811 |
0 |
- |
|
| OCX |
Oncocyte Corp |
Director |
– • – |
2020-12-21 |
4 |
S |
$0.00 |
$13,076 |
D/D |
(35,148) |
315,639 |
0 |
% |
|
| OCX |
Oncocyte Corp |
Director |
– • – |
2020-12-21 |
4 |
OE |
$1.34 |
$64,288 |
D/D |
47,976 |
350,787 |
0 |
- |
|
| OCX |
Oncocyte Corp |
Director |
– • – |
2020-12-22 |
4 |
S |
$0.00 |
$0 |
D/D |
(7,652) |
318,503 |
0 |
% |
|
| OCX |
Oncocyte Corp |
Director |
– • – |
2020-12-22 |
4 |
OE |
$1.34 |
$14,091 |
D/D |
10,516 |
326,155 |
0 |
- |
|
| OCX |
Oncocyte Corp |
Director |
– • – |
2020-12-23 |
4 |
OE |
$1.34 |
$1,658 |
D/D |
1,237 |
319,740 |
0 |
- |
|
| OCX |
Oncocyte Corp |
Director |
– • – |
2020-12-23 |
4 |
S |
$2.55 |
$2,295 |
D/D |
(900) |
318,840 |
0 |
% |
|
| OCX |
Oncocyte Corp |
Director |
– • – |
2020-12-28 |
4 |
OE |
$1.34 |
$87,463 |
D/D |
65,271 |
384,111 |
0 |
- |
|
| OCX |
Oncocyte Corp |
Director |
– • – |
2022-06-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
394,111 |
0 |
- |
|
| OCX |
Oncocyte Corp |
Director |
– • – |
2022-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
404,111 |
0 |
- |
|
| OCX |
Oncocyte Corp |
Director |
– • – |
2022-08-15 |
4 |
B |
$0.97 |
$9,700 |
D/D |
10,000 |
414,111 |
2.39 |
% |
|
| OCX |
Oncocyte Corp |
Director |
– • – |
2022-12-22 |
4 |
B |
$0.29 |
$7,125 |
D/D |
25,000 |
439,111 |
2.39 |
% |
|
| OCX |
Oncocyte Corp |
Director |
– • – |
2023-06-14 |
4 |
B |
$0.21 |
$6,447 |
D/D |
30,000 |
469,111 |
2.39 |
% |
|
| OCX |
Oncocyte Corp |
Director |
– • – |
2023-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
489,111 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2003-10-08 |
4 |
A |
$0.00 |
$0 |
I/I |
80,000 |
814,460 |
|
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2004-01-21 |
4 |
OE |
$1.40 |
$363,108 |
D/D |
259,363 |
2,148,072 |
|
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2004-01-21 |
4/A |
OE |
$1.40 |
$547,567 |
D/D |
391,119 |
2,279,828 |
|
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2004-01-21 |
4/A |
OE |
$1.40 |
$544,662 |
D/D |
389,044 |
2,277,753 |
|
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2004-02-05 |
5 |
A |
$1.40 |
$818,181 |
D/D |
584,415 |
2,864,243 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2004-11-02 |
4 |
A |
$0.00 |
$0 |
I/I |
60,000 |
1,059,670 |
|
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2005-07-14 |
4 |
B |
$0.41 |
$16,400 |
D/D |
40,000 |
2,904,243 |
2.44 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2005-07-20 |
4 |
B |
$0.42 |
$8,400 |
D/D |
20,000 |
2,924,243 |
2.44 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
officerTitle |
– – – |
2005-12-21 |
4 |
OE |
$0.40 |
$534,778 |
D/D |
1,336,946 |
4,261,189 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
